HengLi®

Botulinum toxin type A

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HengLi®, covering 2016-09-26 to 2024-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Botulinum Toxin Type A for Injection (HengLi®) in the Treatment of Trigeminal Neuralgia [Phase 2]